Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy
about
Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab.Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response.Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission.Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
P2860
Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy
description
im August 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2012
@uk
name
Predictive value of peripheral ...... ated with primary chemotherapy
@en
Predictive value of peripheral ...... ated with primary chemotherapy
@nl
type
label
Predictive value of peripheral ...... ated with primary chemotherapy
@en
Predictive value of peripheral ...... ated with primary chemotherapy
@nl
prefLabel
Predictive value of peripheral ...... ated with primary chemotherapy
@en
Predictive value of peripheral ...... ated with primary chemotherapy
@nl
P2093
P1433
P1476
Predictive value of peripheral ...... ated with primary chemotherapy
@en
P2093
Asuncion Chaves Benito
Elena Garcia-Martinez
Enrique Gonzalez Billalabeitia
Maria Angeles Vicente Conesa
Teresa Garcia Garcia
Vicente Vicente Garcia
P304
P356
10.1016/J.BREAST.2011.11.002
P577
2012-08-01T00:00:00Z